Although Col-III expression decreased in the Inj/YAP1KD group, Col-I levels were downregulated (versus Ctl/NC group, P < 0.05), suggesting that YAP1 knockdown may not be an optimal strategy for treating pathological remodeling in tendinopathy. Here, YAP1 is linked to disease of the tendon.